|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our goal was to assess PTX3 as a predictor of systemic inflammatory response syndrome (SIRS), death and disease severity in acute pancreatitis (AP) in comparison to C-reactive protein (CRP) and the APACHE II score.
|
31798002 |
2019 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Eligible records provided data from consecutive AP cases and used CTSI or modified CTSI (mCTSI) alone or in combination with other prognostic scores [Ranson, bedside index of severity in acute pancreatitis (BISAP), Acute Physiology, and Chronic Health Examination II (APACHE II), C-reactive protein (CRP)] for the evaluation of severity or mortality of AP.
|
31507427 |
2019 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Intensive care transfer, AP severity, systemic complications, and prognostic scores (Acute Physiology and Chronic Health Evaluation II [APACHE-II] score ≥ 8, Ranson's score ≥ 3, Bedside Index of Severity in Acute Pancreatitis [BISAP] score ≥ 3, and the systemic inflammatory response syndrome [SIRS] score ≥ 2) significantly correlated with VAT and the VAT/SMT ratio in AP patients.
|
31195984 |
2019 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Serum Creatinine Level and APACHE-II Score within 24 h of Admission Are Effective for Predicting Persistent Organ Failure in Acute Pancreatitis.
|
30984258 |
2019 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
RDW has better prognostic value for SAP patients than the APACHE II and SOFA scores and could easily be used by clinicians for the treatment of SAP patients.
|
31528098 |
2019 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
NLR, PLR, RDW, blood urea nitrogen (BUN), and AP severity scores (SOFA, BISAP, Ranson, and APACHE II) were compared between different severity groups and the survival and death group.
|
31008971 |
2019 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical and demographic data, the Acute Physiology and Chronic Health Evaluation (APACHE II) and the Ranson scores for severity of acute pancreatitis, and the computed tomography (CT) severity index (CTSI) were evaluated.
|
31400275 |
2019 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The moderately severe group of 27 patients (according to Atlanta 2012) had significantly better outcomes when compared to those 47 patients classified as severe form of AP (according to Atlanta 1992) with lower incidence of necrosis and sepsis, lower APACHE II (<i>P</i> = 0.002) and MODS (<i>P</i> = 0.001) scores, shorter ICU stay, decreased need for interventional and surgical treatment.
|
29209119 |
2017 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Regarding the ability for predicting the development of severe complications during the clinical course of AP, the prognostic factor score may be superior to the APACHE II score.
|
28507751 |
2017 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with biochemical and clinical evidence of acute pancreatitis and an APACHE II score > or = 8 were enrolled.
|
16437661 |
2005 |